Neutrophils Activate Tumoral CORTACTIN to Enhance Progression of Orohypopharynx CarcinomaClaudia A. Dumitru, Sven Brandau|Frontiers in Immunology|2013Cited by 30
PLOD2 Is a Prognostic Marker in Glioblastoma That Modulates the Immune Microenvironment and Tumor ProgressionNina Kreße, Claudia A. Dumitru|International Journal of Molecular Sciences|2022Cited by 18
Progesterone Receptor Membrane Component 1 (PGRMC1) Modulates Tumour Progression, the Immune Microenvironment and the Response to Therapy in GlioblastomaClaudia A. Dumitru, I. Erol Sandalcioglu|Cells|2023Cited by 11
The Roles of AGTRAP, ALKBH3, DIVERSIN, NEDD8 and RRM1 in Glioblastoma Pathophysiology and PrognosisClaudia A. Dumitru, I. Erol Sandalcioglu|Biomedicines|2024Cited by 2